RiceBran Technologies (RIBT) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
RiceBran Technologies (RIBT) trades at $0.0002 with AI Score 38/100 (Grade D). RiceBran Technologies specializes in producing and marketing value-added, nutrient-dense products derived from rice and other small grains. Sector: Consumer defensive.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for RIBT: RIBT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RIBT against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RIBT: 3/3 scored disciplines lean bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
RiceBran Technologies (RIBT) Consumer Business Overview
RiceBran Technologies focuses on producing and marketing stabilized rice bran (SRB) and derivative products for the food and animal nutrition industries. With a presence in the United States and internationally, the company converts raw rice bran into value-added ingredients like RiBalance, RiSolubles, and ProRyza, targeting health-conscious consumers and manufacturers.
What Is the Investment Thesis for RIBT?
RiceBran Technologies operates in the niche market of stabilized rice bran and its derivatives, targeting the health and wellness sector. With a market capitalization of $0.00 billion, the company's financial performance shows a profit margin of -39.6% and a gross margin of -1.8%. Growth catalysts include expanding into new international markets and developing innovative applications for its SRB products. However, the company faces risks related to negative profit and gross margins, competition, and reliance on OTC markets. Investors should carefully consider these factors when evaluating RIBT's potential.
Based on FMP financials and quantitative analysis
RIBT Key Highlights
Market capitalization of $0.00 billion, reflecting its small size and potential for growth.
- Negative P/E ratio of -0.00, indicating the company is currently not profitable.
- Profit margin of -39.6%, highlighting the challenges in achieving profitability.
- Gross margin of -1.8%, suggesting difficulties in managing production costs.
- Beta of -0.34, indicating lower volatility compared to the market.
Who Are RIBT's Competitors?
RIBT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BRCNF Burcon NutraScience Corporation | $1.35 | -2.88% | $17.1M | 59 |
| JVA Coffee Holding Co., Inc. | $3.52 | +0.57% | $20.1M | 74 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $2.02 | +0.00% | $35.8M | 64 |
| BUBSF Bubs Australia Limited | $0.08 | +0.00% | $69.2M | 53 |
| LFVN LifeVantage Corporation | $6.58 | +1.31% | $83.1M | 77 |
| FTLF FitLife Brands, Inc. | $10.01 | -2.20% | $94.0M | 59 |
| HBFGF Happy Belly Food Group Inc. | $1.23 | +3.58% | $182M | 57 |
| USNA USANA Health Sciences, Inc. | $13.18 | -0.53% | $243M | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RIBT's Key Strengths?
Proprietary stabilization process for rice bran.
- Range of specialized derivative products.
- Focus on natural and nutrient-dense ingredients.
- Established relationships with manufacturers.
What Are RIBT's Weaknesses?
Negative profit and gross margins.
- Small market capitalization.
- Reliance on OTC markets.
- Limited financial resources.
What Could Drive RIBT Stock Higher?
Expansion into new international markets, targeting increased revenue within 3-5 years.
- Development of new product applications in functional foods and dietary supplements, with an estimated timeline of 1-2 years.
- Establishment of strategic partnerships with food manufacturers to integrate SRB products, expected within the next year.
- Marketing SRB products as feed ingredients in the growing animal nutrition market.
- Leveraging e-commerce platforms to increase direct-to-consumer sales and brand awareness.
What Are the Key Risks for RIBT?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Negative profit and gross margins, indicating financial challenges and operational inefficiencies.
- Intense competition in the packaged foods industry, which could limit market share and pricing power.
- Fluctuations in raw material prices, impacting production costs and profitability.
- Changing consumer preferences, requiring continuous innovation and adaptation.
- Reliance on OTC markets, which increases liquidity risk and regulatory scrutiny.
What Are the Growth Opportunities for RIBT?
- Expansion into International Markets: RiceBran Technologies has the opportunity to expand its presence in international markets, particularly in Asia, where rice is a staple food. By establishing strategic partnerships and distribution networks, RIBT can tap into the growing demand for healthy and natural food ingredients in these regions. This expansion could significantly increase revenue and market share within the next 3-5 years.
- Development of New Product Applications: RIBT can invest in research and development to create new applications for its SRB and derivative products. This includes exploring opportunities in functional foods, dietary supplements, and nutraceuticals. By innovating and diversifying its product offerings, RIBT can attract new customers and increase sales in the health and wellness market. The timeline for new product development is estimated at 1-2 years.
- Strategic Partnerships with Food Manufacturers: Forming strategic partnerships with food manufacturers can provide RIBT with access to established distribution channels and customer bases. By collaborating with these companies, RIBT can integrate its SRB and derivative products into a wider range of food products, increasing brand visibility and market penetration. These partnerships can be established within the next year.
- Focus on Animal Nutrition Market: The animal nutrition market presents a significant growth opportunity for RIBT. By marketing its SRB products as feed ingredients, RIBT can cater to the growing demand for nutritious and sustainable animal feed. This includes targeting livestock, poultry, and aquaculture industries. The animal nutrition market is expected to grow steadily, providing a stable revenue stream for RIBT.
- E-commerce and Direct-to-Consumer Sales: RIBT can leverage e-commerce platforms and direct-to-consumer sales channels to reach a wider audience and increase brand awareness. By establishing an online presence, RIBT can sell its SRB and derivative products directly to consumers, bypassing traditional retail channels. This approach can improve profit margins and provide valuable customer insights. The e-commerce platform can be launched within 6-12 months.
What Are RIBT's Competitive Advantages?
- Proprietary Stabilization Process: The company's proprietary process for stabilizing rice bran prevents rancidity and preserves its nutritional value, creating a competitive advantage.
- Specialized Product Portfolio: RIBT offers a range of specialized derivative products from SRB, catering to specific needs in the food and animal nutrition markets.
- Established Relationships: The company has established relationships with food and animal nutrition manufacturers, providing a stable customer base.
- Focus on Natural Ingredients: RIBT's focus on natural and nutrient-dense ingredients aligns with the growing consumer demand for healthy food options.
What Does RIBT Do?
Founded in 2000 and headquartered in Tomball, Texas, RiceBran Technologies (RIBT) operates as a specialty ingredient company focused on producing, processing, and marketing value-added, healthy, natural, and nutrient-dense products derived from rice and other small grains. Originally known as NutraCea, the company rebranded in October 2012 to reflect its core business. RIBT converts raw rice bran into stabilized rice bran (SRB) using proprietary processes. From SRB, the company creates a range of derivative products, including RiBalance, a complete rice bran nutritional package; RiSolubles, a carbohydrate and lipid-rich fraction; RiFiber, a protein and fiber-rich insoluble derivative; and ProRyza products, which are protein and protein/fiber blends. These SRB and derivative products are marketed as nutritional and beneficial food ingredients, containing a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants. RIBT serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally, positioning itself as a provider of ingredients that enhance the nutritional value of consumer products.
What Products and Services Does RIBT Offer?
- Produces stabilized rice bran (SRB) from raw rice bran.
- Creates derivative products from SRB, including RiBalance, RiSolubles, RiFiber, and ProRyza.
- Markets SRB and derivative products to food and animal nutrition manufacturers.
- Serves wholesalers and retailers in the United States and internationally.
- Offers ingredients rich in oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants.
- Provides solutions for enhancing the nutritional value of consumer products.
How Does RIBT Make Money?
- Converts raw rice bran into stabilized rice bran (SRB) using proprietary processes.
- Develops and markets high-value derivative products from SRB.
- Sells SRB and derivative products to food and animal nutrition industries.
- Generates revenue through product sales to manufacturers, wholesalers, and retailers.
What Industry Does RIBT Operate In?
RiceBran Technologies operates within the packaged foods industry, which is characterized by intense competition and evolving consumer preferences for healthier and more nutritious options. The global health and wellness market is experiencing significant growth, driven by increased consumer awareness of the benefits of healthy eating. RIBT aims to capitalize on this trend by offering SRB and derivative products that cater to the demand for natural and nutrient-dense ingredients. Competitors include companies offering similar ingredients and solutions in the food and animal nutrition sectors.
Who Are RIBT's Key Customers?
- Food manufacturers seeking to enhance the nutritional value of their products.
- Animal nutrition manufacturers requiring nutritious feed ingredients.
- Wholesalers distributing food and animal nutrition products.
- Retailers selling food and animal nutrition products to consumers.
Forward Outlook
Wall Street analysts project RiceBran Technologies revenue of about $13.8M for fiscal 2026, with EPS near $-9.15.
RIBT Valuation & Market Position
Relative to its peer group, RIBT's quantitative score of 38/100 is below the peer average of 65/100.
Key Financial Metrics
Return on assets is -96.3%, showing how much profit it generates from its asset base. A current ratio of 0.54 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
RiceBran Technologies's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Company Profile
RiceBran Technologies operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Tomball, US. The company is led by CEO Eric Tompkins. RIBT has traded publicly since 2003.
RIBT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying indicates confidence in the company's future, suggesting a positive outlook from those closest to the business.
- Community sentiment has shifted positively, with discussions highlighting the potential for growth in the health food sector, where RiceBran operates.
- Market developments show increased interest in plant-based and healthy food options, aligning with RiceBran's product offerings and positioning.
- Positive reviews and endorsements from health influencers have boosted brand visibility, enhancing community perception and interest.
Bear Case
- Concerns over supply chain disruptions have been raised, which could impact production and delivery timelines for RiceBran's products.
- Community discussions reflect skepticism regarding the scalability of RiceBran's operations, with some questioning the company's ability to meet rising demand.
- Recent earnings reports have shown mixed results, leading to uncertainty about the company’s financial stability and growth trajectory.
- Increased competition in the health food market poses a threat, as established brands may overshadow RiceBran's offerings, impacting market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
RIBT Latest News
No recent news available for RIBT.
RIBT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RIBT.
Price Targets
Wall Street price target analysis for RIBT.
RIBT MoonshotScore
What does this score mean?
The MoonshotScore rates RIBT 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Eric Tompkins
CEO
Eric Tompkins serves as the CEO of RiceBran Technologies, overseeing the company's operations and strategic direction. Information regarding his prior experience and educational background is not available in the provided data. As CEO, he manages a team of 35 employees and is responsible for driving the company's growth and profitability in the specialty ingredient market.
Track Record: Due to the limited information available, it is not possible to assess Eric Tompkins's track record or key achievements at RiceBran Technologies. His tenure and significant milestones under his leadership are unknown based on the provided data.
RIBT OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that RiceBran Technologies may not meet the minimum financial or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with distressed financials, penny stocks, or those that choose not to comply with stricter reporting standards.
- OTC Tier: OTC Other
- Limited Financial Disclosure: The lack of comprehensive financial reporting increases the difficulty of assessing the company's financial health and performance.
- Low Liquidity: Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares without impacting the price.
- Price Volatility: OTC stocks are often subject to greater price volatility due to limited trading activity and market sentiment.
- Regulatory Scrutiny: Companies on the OTC Other tier may face increased regulatory scrutiny due to their limited compliance with reporting standards.
- Going Concern Risk: Companies in this tier may have a higher risk of financial distress or going concern issues.
- Verify the company's financial statements and SEC filings (if available).
- Assess the company's management team and their experience.
- Evaluate the company's business model and competitive landscape.
- Review the company's OTC Markets profile and disclosure statements.
- Check for any legal or regulatory issues.
- Monitor trading volume and price activity.
- Consult with a financial advisor.
- Operational History: RiceBran Technologies has been in operation since 2000, indicating a degree of stability and experience in the specialty ingredient market.
- Product Portfolio: The company offers a range of SRB and derivative products, suggesting a focus on innovation and product development.
- Customer Base: RIBT serves food and animal nutrition manufacturers, wholesalers, and retailers, indicating a diversified customer base.
- Name Change: The company changed its name from NutraCea to RiceBran Technologies in 2012, which could indicate a strategic shift or rebranding effort.
- Employee Count: The company has 35 employees.
RiceBran Technologies Consumer Defensive Stock: Key Questions Answered
What does the AI Score mean for RIBT?
RIBT holds an AI Score of 38/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. RiceBran Technologies specializes in producing and marketing value-added, nutrient-dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice …
What does RiceBran Technologies do?
RiceBran Technologies specializes in the production and marketing of value-added ingredients derived from rice bran. The company converts raw rice bran into stabilized rice bran (SRB) and further processes it into derivative products like RiBalance, RiSolubles, RiFiber, and ProRyza.
What do analysts say about RIBT stock?
Based on available data, there is no analyst coverage information provided for RiceBran Technologies (RIBT). The company's financial metrics include a market capitalization of $0.00 billion, a negative P/E ratio, and negative profit and gross margins. These metrics suggest that the company is currently facing financial challenges. Investors should conduct their own thorough research and consider the company's OTC listing, financial performance, and growth opportunities when evaluating RIBT's potential.
What are the main risks for RIBT?
RiceBran Technologies faces several key risks. Its negative profit and gross margins indicate financial instability and operational inefficiencies. Intense competition in the packaged foods industry could limit its market share and pricing power. Fluctuations in raw material prices, particularly rice bran, can impact production costs and profitability. Changing consumer preferences for healthier and more sustainable products require continuous innovation.
What are the key factors to evaluate for RIBT?
RiceBran Technologies (RIBT) holds an AI score of 38/100 (low). RiceBran Technologies operates in the niche market of stabilized rice bran and its derivatives, targeting the health and wellness sector. Not financial advice.
How frequently does RIBT data refresh on this page?
RIBT's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven RIBT's recent stock price performance?
RiceBran Technologies (RIBT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary stabilization process for rice bran. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RIBT overvalued or undervalued right now?
RiceBran Technologies (RIBT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research RIBT before investing?
Before investing in RiceBran Technologies (RIBT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available.
- OTC market carries higher risk.
- AI analysis pending.